Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study.
机构:[1]Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.北京朝阳医院[2]Department of Thoracic Surgery, West China Hospital, West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.四川大学华西医院[3]Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.[4]Department of Thoracic Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.[5]Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.[6]Department of Thoracic Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing, China.首都医科大学宣武医院
第一作者机构:[1]Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构:[1]Department of Thoracic Surgery, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.[*1]Department of Thoracic Surgery, Beijing Chaoyang Hospital, Capital Medical University, 100020 Beijing, China
推荐引用方式(GB/T 7714):
Ke Lihui,Cui Songping,Yang Mei,et al.Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study.[J].JOURNAL OF SURGICAL ONCOLOGY.2022,125(5):933-942.doi:10.1002/jso.26794.
APA:
Ke Lihui,Cui Songping,Yang Mei,Chen Jun,Xu Shun...&Li Hui.(2022).Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study..JOURNAL OF SURGICAL ONCOLOGY,125,(5)
MLA:
Ke Lihui,et al."Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross-sectional observational study.".JOURNAL OF SURGICAL ONCOLOGY 125..5(2022):933-942